Publications en collaboration avec des chercheurs de Hospital Universitario 12 de Octubre (20)

2023

  1. Real-life outcomes in biotypes of psychotic disorders based on neurocognitive performance

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 273, Núm. 6, pp. 1379-1386

2022

  1. Four-month incidence of suicidal thoughts and behaviors among healthcare workers after the first wave of the Spain COVID-19 pandemic

    Journal of Psychiatric Research, Vol. 149, pp. 10-17

  2. Relation between EEG resting-state power and modulation of P300 task-related activity in theta band in schizophrenia

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 116

2021

  1. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis

    Schizophrenia Research, Vol. 236, pp. 19-28

  2. Paliperidone Reversion of Maternal Immune Activation-Induced Changes on Brain Serotonin and Kynurenine Pathways

    Frontiers in Pharmacology, Vol. 12

2020

  1. Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study

    Schizophrenia Research, Vol. 218, pp. 292-294

  2. Deficits of entropy modulation of the EEG: A biomarker for altered function in schizophrenia and bipolar disorder?

    Journal of Psychiatry and Neuroscience, Vol. 45, Núm. 5, pp. 322-333

2019

  1. Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3863-3872

  2. Erratum: Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (3863–3872) DOI: 10.1073/pnas.1815034116)

    Proceedings of the National Academy of Sciences of the United States of America

2018

  1. Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: Effect of antidepressants

    Journal of Neuroinflammation, Vol. 15, Núm. 1

2017

  1. Paliperidone reverts Toll-like receptor 3 signaling pathway activation and cognitive deficits in a maternal immune activation mouse model of schizophrenia

    Neuropharmacology, Vol. 116, pp. 196-207

  2. Persistent negative symptoms in first-episode psychosis: Early cognitive and social functioning correlates and differences between early and adult onset

    Journal of Clinical Psychiatry, Vol. 78, Núm. 9, pp. 1414-1422

2016

  1. Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer

    Oncotarget, Vol. 7, Núm. 30, pp. 47565-47575

  2. Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia

    Journal of Psychiatry and Neuroscience, Vol. 41, Núm. 3, pp. E46-E55

2005

  1. Neurotransmitter amino acid in cerebrospinal fluid of patients with dementia with Lewy bodies

    Journal of Neural Transmission, Vol. 112, Núm. 4, pp. 557-563

  2. Time course of opioid and cannabinoid gene transcription alterations induced by repeated administration with fluoxetine in the rat brain

    Neuropharmacology, Vol. 49, Núm. 5, pp. 618-626

  3. κ- and δ-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice

    European Journal of Neuroscience, Vol. 22, Núm. 8, pp. 2106-2110

2004

  1. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors

    Neuropharmacology, Vol. 46, Núm. 7, pp. 966-973

  2. Role of endocannabinoid system in mental diseases

    Neurotoxicity Research, Vol. 6, Núm. 3, pp. 213-224

2002

  1. Cerebrospinal fluid and plasma concentrations of nitric oxide metabolites are increased in dementia with Lewy bodies

    Neuroscience Letters, Vol. 333, Núm. 2, pp. 151-153